sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Machinery & Construction

Solid Phase Extraction Spe Equipment MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy TechnologyBy End UseBy Automation Level

Full title & scope — all 5 axes with their segments

Solid Phase Extraction Spe Equipment Market Size, Share & Industry Analysis, By Type (SPE Cartridges, SPE Disk, Well Plate), By Application (Chemical, Food, Biological, Others), By Technology (Reverse Phase, Normal Phase, Ion Exchange, Mixed Mode), By End Use (Pharmaceutical & Biotechnology Companies, Environmental Testing Laboratories, Food & Beverage Testing Laboratories, Forensic & Clinical Laboratories, Academic & Research Institutes), By Automation Level (Manual SPE Systems, Automated/Robotic SPE Systems), and Regional Forecast, 2026-2034

Last Updated: Sep 24, 2026Report ID: CDI-116026
Methodology

How the estimates were built: data sources, modelling approach and validation steps.

Research approach

A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.

Market size estimation, this report

The estimate is built upward from unit volumes and realized prices for the three product forms sold in this market: cartridges, extraction disks and well plates. Cartridge and plate shipment volumes are estimated from consumables manufacturers' production disclosures and distributor sell-through data, multiplied by average selling prices across bed-mass and plate-well-count configurations. Automated system unit counts and average prices are added separately, since a robotic platform sells at a different price point than a manual cartridge rack. This bottom-up build is then checked against the sample-preparation revenue lines disclosed by Thermo Fisher Scientific, Waters, Agilent, Merck and Biotage. Where the two diverge, the bottom-up unit-price or volume assumption is corrected; the disclosed figure is not averaged in.

The four stages

The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.

1
Scope and segmentation
2
Bottom-up sizing
3
Reconciliation
4
Forecast

What the build rests on, and what checks it

The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.

The bottom-up build rests on
  • Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
  • Realised pricing by tier and channel, rather than one blended average applied across the whole market
  • Take-up and frequency: how much of the addressable base buys, and how often it repeats
The build is checked against
  • Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
  • Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
  • Trade and customs flows, where the product crosses borders in a separately recorded form
Bottom-up sequence
1
Size the base
2
Apply take-up
3
Apply frequency
4
Apply realised price
Reconciliation sequence
1
Gather disclosed revenue
2
Strip out-of-scope lines
3
Compare against the build
4
Correct the assumption

Data sources

Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.

Primary — who is interviewed
  • Commercial and product leadership at the companies that supply the market
  • Procurement and specification leads at the organisations that buy it
  • Distributors, integrators and channel partners, where the market is served indirectly
  • Regulatory and standards specialists, where approval governs what can be sold at all
Secondary — what is read
  • Company filings, annual reports and investor disclosure
  • Government statistics, customs records and regulatory registers
  • Trade association output and standards-body publications
  • Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Primary research design, this report

Interview targets are chosen for the roles that actually decide an SPE purchase: laboratory procurement and instrument managers at contract-testing and pharmaceutical quality-control labs, method-development chemists who select cartridge or plate chemistry for a given analyte class, and channel managers at the distributors that carry cartridge and disk lines into smaller testing labs. Regulatory affairs contacts at environmental and food-testing laboratories are included to gauge how mandated residue-screening panels translate into extraction volume. Sampling is weighted toward North America and Europe, where pharmaceutical and environmental testing capacity concentrates, with additional coverage in China and India to capture the faster-growing contract-testing base in Asia Pacific.

Secondary sources, this report

Desk research draws on the FDA's bioanalytical method validation guidance and equivalent EMA guidelines, which set the extraction and recovery standards that determine cartridge chemistry selection. U.S. EPA method compendia (Method 525, Method 8270 and related solid-phase extraction protocols) anchor volume estimates for environmental testing. Food-safety residue limits published under Codex Alimentarius and EU Regulation 396/2005 inform the food-testing segment. Trade classification data under HS code 3822 for diagnostic and laboratory reagents is used to cross-check cross-border shipment volumes, alongside laboratory-products segment disclosures filed by the major suppliers named in this report.

Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.

Forecasting

The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.

Forecast approach, this report

The forecast is built from three assumptions: continued expansion of bioanalytical and clinical testing volume as drug pipelines and diagnostic panels grow, a steady shift of sample throughput from manual cartridges to automated well-plate systems as labs scale, and tightening residue-screening mandates in food and environmental testing that add extraction volume independent of underlying test-market growth. Pricing is assumed to hold flat in real terms, since cartridge and plate chemistry is a mature, competitively supplied category. For the forecast to hold, testing-laboratory capacity must keep expanding at close to its recent pace and no major regulatory rollback of residue-screening requirements should occur in the largest testing markets.

Triangulation and validation

No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.

Validation, this report

Historical output for 2020 through 2024 is back-tested against recorded growth in laboratory-consumables spending and against the bioanalytical and environmental-testing capacity data published by national laboratory-accreditation bodies. Segment-share shifts, in particular the move from cartridges toward automated well-plate formats, are reviewed against equipment order patterns disclosed by the automation-system suppliers in this report. Sensitivities are tested on the two assumptions most likely to move the forecast: the pace of automation adoption and the rate at which residue-screening mandates expand testing volume. Both are flexed independently to confirm the base case does not depend on either assumption holding at its most favorable value.

Confidence and limitations

Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.

Confidence framing, this report

Confidence is firmer for the cartridge and well-plate product lines and for the pharmaceutical and environmental end uses, where supplier disclosures and testing-volume data are available and consistent with each other. It is thinner for the academic and research end-use segment, where purchasing is dispersed across many small institutional buyers and reporting is sparse, and for the disk format, which several suppliers fold into broader sample-preparation lines instead of reporting it separately. A structural risk worth naming is regulatory change: a material loosening of residue-screening requirements in a large testing market would lower extraction volume growth faster than this forecast assumes.

Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Solid Phase Extraction Spe Equipment Market projected to reach?

USD 789 Million by 2034, CAGR 7.95%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 33.6% of global revenue through 2034.

05Which segment leads the market?

SPE Cartridges is the largest line by Type, at 57.8% of revenue in 2025.

06Who are the key companies profiled?

Thermo Fisher Scientific, Avantor Performance Materials, Waters Corporation, Agilent Technologies, S*Pure Pte Ltd, Merck, Biotage, PerkinElmer, 3M, GL Sciences, Restek Corporation, Orochem Technologies, Tecan SP, ANPEL Laboratory Technologies. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 3060 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.